"Biovest retains Ferghana Partners to evaluate strategic transactions (BVTI) 0.39 -0.01 : Co announced that Biovest has retained Ferghana Partners as the Company's strategic transaction advisor to evaluate/implement creative financings and partnering opportunities on a regional or global basis for BiovaxID, its late-stage personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma. "